Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs versus placebo after tibial or femoral shaft fracture surgery
ACTRN12619001376134Phase 2Not yet recruiting
- Sponsor
- Monash University
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of parecoxib and celecoxib in tibial diaphyseal fracture and Femoral diaphyseal fracture (2 arms), sponsored by Monash University. Primary endpoints: Patient adherence and Physician adherence. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
parecoxibcelecoxib
03
Conditions
tibial diaphyseal fractureFemoral diaphyseal fracture
Beyond the preview
Go deeper on ACTRN12619001376134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001376134.